Subscribe to the Hub's Newsletter and stay up to date on the latest news, events and opportunities of the digital health ecosystem.
Putting the patient at the centre of decision-making in the pharmaceutical industry companies involved in the research, development and distribution of medicines and medical devices requires major changes and the participation of all the agents involved in decision-making.
That is why, for four years now, BHH member Elogia Pharma has wanted to accompany the industry in its patient-centric strategies, promoting the Patient Digital Touchpoints Studies. In them, they provide information to understand the patient and their behaviour.
On this occasion, they invite you to a webinar titled 'The Digital Journey in the purchase of OTC drugs', in which they advance the results of their IV Patient Digital Touchpoints Study 2024 OTC category.
Knowing a patient's path to purchase allows both pharmacies and pharmaceutical companies to create more effective marketing strategies, tailoring their messages to address the specific needs of each patient segment.
If they are clear about where and how their audience is being informed, they have a good chance of influencing their decision making.
Register now for the webinar on April 11th at 10 hrs HERE.